SkyePharma AG: Clinical Trials

6 completed. 6 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	6	Completed 6

Follow SkyePharma AG: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005 SKP FlutiForm HFA pMDI - Asthma	Phase 3	Completed	SkyePharma AG	280	2008-09-01	2011-06-23
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults FlutiForm 250/10, SKP-Fluticasone, Flovent Fluticasone HFA - Asthma	Phase 3	Completed	SkyePharma AG	438	2008-03-01	2010-08-27
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma Fluticasone propionate/formoterol fumarate 100/10, Fluticasone propionate 100, Formoterol fumarate 10 - Asthma	Phase 3	Completed	SkyePharma AG	475	2006-07-01	2011-06-23
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma Fluticasone propionate/Formoterol fumarate 250/10, Placebo, Fluticasone propionate/Formoterol fumarate 100/10 - Asthma	Phase 3	Completed	SkyePharma AG	557	2006-06-01	2011-06-23
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma Fluticasone propionate/Formoterol Fumarate 100/10, Fluticasone propionate 100, Formoterol fumarate 10 - Asthma	Phase 3	Completed	SkyePharma AG	357	2006-06-01	2011-06-23
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma Fluticasone propionate/formoterol fumarate - Asthma	Phase 3	Completed	SkyePharma AG	400	2006-03-01	2010-08-27

Conditions studied

Asthma (6)

Interventions

Fluticasone (6)  ·  Formoterol Fumarate (2)  ·  fluticasone-formoterol (1)

Countries

United States (5)  ·  Romania (3)  ·  Canada (2)  ·  Hungary (2)  ·  Mexico (2)  ·  Peru (2)  ·  Poland (2)  ·  Ukraine (2)  ·  Argentina (1)  ·  Chile (1)  ·  Germany (1)  ·  Puerto Rico (1)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Thao T Doan, MD (1)

Results publications

PMID 23078148, PMID 23098325, PMID 23865726, PMID 23870606